The FDA has approved alemtuzumab (Lemtrada) for the treatment of patients with relapsing forms of multiple sclerosis.
HCPLive Staff
Advertisement
Articles by HCPLive Staff
The FDA has approved a supplemental new drug application for avanafil (Stendra) to treat erectile dysfunction in men.
Advertisement
Latest Updated Articles
- FDA Approves sNDA for Oral Erectile Dysfunction Treatment
September 18th 2014
- FDA Approves Alemtuzumab for Relapsing Forms of Multiple Sclerosis
November 15th 2014
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric Patients
2
Pharmacists Are Critical to SGLT2, GLP-1 Use in CKD
3
FDA Expands Lutetium Lu 177 Vipivotide Tetraxetan to mHSPC, Nearly Doubling Eligible Population
4
Inside Phoebe Putney’s Medication Management Clinic: How One Rural Health System Saved $1 Million and Cut Readmissions
5